Birmingham Tissue Analytics is based in the Institute of Translational Medicine and provides a high level digital spatial imaging service for academic-led research and industry contracts.
These capabilities enable researchers to build a thorough picture of cellular composition in both inflammatory diseases and cancer, identifying shared and distinct mechanisms and targets across diseases and delivering outcomes for novel early phase clinical trials that can accelerate successful development of precision-based therapeutics. Implementation of GCP standards forms a key part of the delivery of our analytic capabilities. Pre-clinical collaborative research can be conducted to a standard suitable to progress to clinical trials, alongside development of novel and robust tissue-based clinical trial outcomes on which to base the success of novel therapeutics.
Who do we work with?
BTA brings together highly skilled specialist staff in tissue imaging and analysis to support both academic and industry-led projects with a wealth of experience in the inflammation and cancer space.
We link with a range of facilities across the Birmingham Health Partners network including Genomics Birmingham, the Clinical Immunology Service and University Hospitals Birmingham pathology. To deliver lab-based outcome measures for early phase clinical trials we work closely with the I-ACT (Inflammation and Advanced Therapy) Trials Team, based in the CRCTU.
BTA services are available to both internal and external academics in inflammation and cancer and industry professionals with interests in targeting inflammatory diseases or industry professionals in the digital pathology space.